OTCMKTS:ARNI

Arno Therapeutics (ARNI) Stock Price, News & Analysis

$0.0003
0.00 (0.00%)
(As of 05/3/2024 ET)
Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.0001
$0.0003
Volume
N/A
Average Volume
8,820 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ARNI stock logo

About Arno Therapeutics Stock (OTCMKTS:ARNI)

Arno Therapeutics, Inc., a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men. Its product development pipeline also consists of AR-12, an orally available cancer treatment, which has completed Phase I clinical study for the treatment of solid tumors and hematological malignancies, as well as in Pre-clinical studies for the treatment of various anti-microbial targets. In addition, the company's product development pipeline comprises AR-42, a novel orally available cancer therapy that is in Phase I investigator-initiated clinical study for the treatment of hematological malignancies and solid tumors. The company has license agreements with Invivis Pharmaceuticals, Inc.; the Regents of the University of Minnesota; and the Ohio State University Innovation Foundation, as well as a co-development agreement with Leica Biosystems Newcastle Ltd. Arno Therapeutics, Inc. was founded in 2005 and is based in Flemington, New Jersey.

ARNI Stock Price History

ARNI Stock News Headlines

Arno Penzias obituary
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
Engine 2 dedicates new truck to Jason Arno
Marjorie Arni
RANI - Rani Therapeutics Holdings, Inc.
See More Headlines
Receive ARNI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arno Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:ARNI
CUSIP
042564203
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

ARNI Stock Analysis - Frequently Asked Questions

How have ARNI shares performed in 2024?

Arno Therapeutics' stock was trading at $0.0001 at the beginning of the year. Since then, ARNI shares have increased by 200.0% and is now trading at $0.0003.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Arno Therapeutics own?
How do I buy shares of Arno Therapeutics?

Shares of ARNI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ARNI) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners